British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
Clinical Trials & Research: The Importance of the Patient’s Perspective
Last year, Neuroendocrine Cancer UK's Patient Support Co-ordinator, and neuroendocrine cancer patient, Kate, gave a presentation to Ipsen, the manufacturer of Lanreotide, a monthly Somatostatin Analogue prescribed to many members of our patient community. The...
UKI NETS 21st Annual Conference 2023 – Registration Open
UKI NETS 21st Annual Conference 2023 – Sheffield City Hall Monday 4th December The UKI NETS 21st Annual conference will be held in person at Sheffield City Hall. We continue to support our NET community and to promote collaborations, education and advancement of...
Neuroendocrine cancer: an ideal patient care pathway: Addressing inequities in diagnosis, care, and support.
Neuroendocrine cancers, also known as neuroendocrine neoplasms (NENs), are a diverse group of cancers that have been increasing in incidence and prevalence in England, as well as across the UK and the world. Developing a patient care pathway for neuroendocrine cancer...